Melanoma Management
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.1 | Q4 | 10.5% | 0.398 | Q3 | 53.1% |
| 2024 | 0.7 | Q4 | 8.6% | 0.296 | Q3 | 45.2% |
| 2023 | 1.0 | Q4 | 12.7% | 0.945 | Q1 | 84.1% |
| 2022 | 3.6 | 54.5% | 0.699 | Q1 | 76.8% | |
| 2021 | — | 25.2% | — | 0.5% | ||
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | 0.146 | Q4 | 27.0% | |
| 2018 | — | — | 0.124 | Q4 | 10.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2045-0885
ISSN
2045-0893
region
Western Europe
coverage
2014-2026